Alembic Pharmaceuticals Limited (APL) has posted a 12 per cent growth in net profit for the quarter ended March 31, to Rs 251 crore, from Rs 225 crore during the corresponding period last year. The company s net sales were up six per cent to Rs 1,280 crore, from Rs 1,207 crore. On a full-year basis, the company s net profit rose 42 per cent to Rs 1,178 crore for FY21, from Rs 829 crore in FY20, while net sales were up 17 per cent to Rs 5,393 crore (Rs 4,606 crore). Commenting on the results, Alembic Pharmaceuticals Limited managing director Pranav Amin said the fiscal was an outstanding year , with the company recording its highest-ever sales and profit. This was led by strong growth in the API and international businesses. The operating teams worked tirelessly through the pandemic to ensure critical supplies were uninterrupted, Amin added.